Suppr超能文献

针对癌症患儿的体育锻炼与心理社会训练相结合的干预措施的成本效益:“运动中的生活质量”研究结果

Cost-effectiveness of a combined physical exercise and psychosocial training intervention for children with cancer: Results from the quality of life in motion study.

作者信息

Braam K I, van Dijk-Lokkart E M, van Dongen J M, van Litsenburg R R L, Takken T, Huisman J, Merks J H M, Bosmans J E, Hakkenbrak N A G, Bierings M B, van den Heuvel-Eibrink M M, Veening M A, van Dulmen-den Broeder E, Kaspers G J L

机构信息

Department of Paediatric Oncology/Haematology, VU University Medical Center, Amsterdam, The Netherlands.

Department of Medical Psychology, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12586. Epub 2016 Oct 10.

Abstract

This study was performed to estimate the cost-effectiveness of a combined physical exercise and psychosocial intervention for children with cancer compared with usual care. Sixty-eight children, aged 8-18 years old, during or within the first year post-cancer treatment were randomised to the intervention (n = 30) and control group (n = 38). Health outcomes included fitness, muscle strength and quality adjusted life years; all administered at baseline, 4- and 12-month follow-up. Costs were gathered by 1 monthly cost questionnaires over 12 months, supplemented by medication data obtained from pharmacies. Results showed no significant differences in costs and effects between the intervention and control group at 12-month follow-up. On average, societal costs were €299 higher in the intervention group than in the control group, but this difference was not significant. Cost-effectiveness acceptability curves indicated that the intervention needs large societal investments to reach reasonable probabilities of cost-effectiveness for quality of life and lower body muscle strength. Based on the results of this study, the intervention is not cost-effective in comparison with usual care.

摘要

本研究旨在评估与常规护理相比,针对癌症患儿的体育锻炼与心理社会干预相结合的成本效益。68名年龄在8至18岁之间、处于癌症治疗期间或治疗后第一年的儿童被随机分为干预组(n = 30)和对照组(n = 38)。健康结局包括体能、肌肉力量和质量调整生命年;所有指标均在基线、4个月和12个月随访时进行测量。通过12个月的每月成本问卷收集成本,并辅以从药房获得的用药数据。结果显示,在12个月随访时,干预组和对照组在成本和效果方面没有显著差异。平均而言,干预组的社会成本比对照组高299欧元,但这一差异并不显著。成本效益可接受性曲线表明,该干预需要大量的社会投资,才能达到在生活质量和下肢肌肉力量方面具有合理成本效益概率的目标。基于本研究结果,与常规护理相比,该干预不具有成本效益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验